Clinical characteristics of lung transplant (LT) recipients
| Subjects n | 29 |
| Age years | 48.7±13.6 |
| Male sex n (%) | 14 (48) |
| Age at the time of LT years | 34.7±14.0 |
| Years since LT | 14.0±3.1 |
| Diagnosis | |
| COPD | 3±10.3 |
| ILD | 4±13.7 |
| CF | 14±48.3 |
| Bronchiectasis | 1±3.5 |
| PH | 1±3.5 |
| Other | 6±20.7 |
| BMI kg·m−2 | 21.6±5.6 |
| FFMI kg·m−2 | 16.6±4.1 |
| Haemoglobin g·dL−1 | 13.3±1.5 |
| Arterial hypertension n (%) | 15 (51.7) |
| Diabetes mellitus n (%) | 6 (20.7) |
| Dyslipidaemia n (%) | 11 (37.9) |
| Smoking history n (%) | |
| Never smoked | 21 (72.4) |
| Former smoker | 8 (27.6) |
| Packs per year | 29.7±23.4 |
| Lung function | |
| FVC L | 3.9±0.92 |
| FVC % predicted | 92.6±15.7 |
| FEV1 L | 3.1±0.7 |
| FEV1 % predicted | 97.9±14.5 |
| DLCO (mL·mmHg−1·min−1) median (IQR) | 77.1 (70–83.3) |
| TLC % predicted | 96.1±18.3 |
| RV % predicted | 81.0±8.5 |
| Oral corticosteroids n (%) | 28 (96.6) |
| Oral corticosteroids dosage mg | 3.9±1.6 |
Data are presented as mean±sd, unless otherwise stated. Some variables have missing values: eight in FFMI, one in packs per year and one in corticosteroid dosage. ILD: interstitial lung disease; CF: cystic fibrosis; PH: pulmonary hypertension; BMI: body mass index; FFMI: fat-free mass index; FVC: forced vital capacity; FEV1: forced expiratory volume in 1 s; DLCO: diffusing capacity of the lung for carbon monoxide; IQR: interquartile range; TLC: total lung capacity; RV: residual volume.